SCHEMBL30291306

SCHEMBL30291306

NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.61
ERAP2 Q6P179 4/20 0.59
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 1/20 0.56
MPO P05164 1/20 0.56
MAPT P10636 1/20 0.56
TSHR P16473 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
KMT2A Q03164 1/20 0.56
HIF1A Q16665 1/20 0.56
ACE P12821 2/20 0.55
NPY1R P25929 3/20 0.55
NPY2R P49146 3/20 0.55
NPY4R P50391 3/20 0.55
IL1RN P18510 3/20 0.54
ERAP1 Q9NZ08 3/20 0.54
ANPEP P15144 2/20 0.54
LNPEP Q9UIQ6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30291169 0.94 ERAP2 (0.58) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL1898076 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL3053743 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
SCHEMBL31273729 0.92 ECE1 (0.62) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL1898073 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL24454642 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL5822555 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL2042188 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL5822559 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA
Oglufanide SCHEMBL5735529 0.92 ERAP2 (0.68) ECE1ERAP2KDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355367-A1 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS Barinthus Biotherapeutics North America, Inc. (US) 2024-04-24 EP disclosed
WO-2022266340-A1 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS VACCITECH NORTH AMERICA, INC. (US) 2022-12-22 WO disclosed